Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Ventas Reports 2021 Third Quarter Results

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2021.

“Ventas’s high-quality diversified portfolio demonstrated strength in the third quarter of 2021 despite the challenges of COVID-19 and a tight labor market. We are pleased with the growth in our life science, medical office and healthcare triple net portfolios. We are also seeing sustained demand and revenue growth in our senior housing communities, with third quarter average occupancy up 230 basis points sequentially and eight consecutive months of occupancy growth through October,” said Debra A. Cafaro, Ventas Chairman and CEO.

“We continue to drive growth through $3.7 billion of completed and announced strategic investments in 2021, including our recent acquisition of 103 independent living communities owned by New Senior for a purchase price of $2.3 billion and the development of a $0.5 billion life science project anchored by University of California, Davis. We are committed to expanding our senior living, life science and medical office footprints through relationship-driven investments that enhance our portfolio and drive returns.

“Looking ahead, we are excited for the future of Ventas and expect a robust recovery in senior housing as we also capture the benefits of our completed investments and execute on our external growth opportunities,” Cafaro concluded.

Third Quarter 2021 Results

For the third quarter 2021, reported per share results were:

 

Quarter Ended September 30

 

2021

2020

$ Change

% Change

Net Income (Loss) Attributable to Common Stockholders

$0.16

$0.03

$0.13

433%

Nareit FFO Attributable to Common Stockholders (“Nareit FFO”)*

$0.58

$0.65

($0.07)

(11%)

Normalized FFO Attributable to Common Stockholders (“Normalized FFO”)*

$0.73

$0.75

($0.02)

(3%)

 

 

 

 

 

* This is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.

Third Quarter 2021 Property Results

 

 

 

3Q21 vs. 3Q20 (Quarterly Pools)

Year-Over-Year

Same-Store Cash Net Operating Income (“NOI”)* Growth

 

 

Assets

% Change

% Change (ex. BKD Cons)1

SHOP

 

306

(12.7%)

(12.7%)

NNN

 

338

(54.7%)

(0.8%)

Office

 

335

4.2%

4.2%

Total Company

 

979

(32.4%)

(3.0%)

 

 

 

 

 

 

 

 

3Q21 vs. 2Q21 (Sequential Pools)

Sequential

Same-Store Cash NOI* Growth

 

 

 

Assets

% Change

 

SHOP

 

322

(3.4%)

 

NNN

 

340

0.5%

 

Office2

 

335

(7.7%)

 

Total Company2

 

997

(3.5%)

 

* This is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.

  1. 3Q21 vs. 3Q20 NNN same-store cash NOI growth adjusted to exclude the benefit of $162 million in upfront cash consideration received as part of the Brookdale lease modification agreement in July 2020.
  2. Office segment benefited from a $12 million lease termination payment in 2Q21. Excluding the impact of this payment, sequential same-store cash NOI growth would have been 1.2% in 3Q21 for the Office segment and (0.4%) for Total Company.

Third Quarter Same-Store Property Results and Latest SHOP Trends

  • Company Results
    • Sequential same-store third quarter 2021 cash NOI decreased 3.5% and decreased 0.4% excluding the impact of a $12 million cash lease termination fee in the Life Science, R&I portfolio received in the second quarter.
  • SHOP (30% of Total Portfolio)
    • Sequential Same-Store Pool (322 assets) Performance: Average SHOP occupancy grew 230 basis points to 82.2% in the third quarter versus the second quarter 2021. Approximate spot occupancy increased 183 basis points from June 30 to September 30, led by U.S. SHOP communities. Revenue increased 3.1% in the third quarter due to higher occupancy and stronger pricing versus the second quarter, with RevPOR improving sequentially by 0.3%. Expenses increased 5.4% in the third quarter principally as a result of higher labor costs, which represented approximately half of the increase. Other cost increases included the additional day in the quarter and seasonal repair and maintenance expenses. SHOP sequential same-store cash NOI decreased 3.4% in the third quarter.
    • Clinical Trends: SHOP communities continue to experience de minimis confirmed resident cases of COVID-19, with high vaccination rates among residents and staff members. Of Ventas’s SHOP communities, 99% have never reported a resident case or have not reported a new case in the last seven days. Clinics for both the flu vaccine and the COVID-19 booster have begun in Ventas’s senior living communities to further protect residents and employees.
    • October Trends: October was the eighth consecutive month of occupancy improvement. Leading indicators including leads and move-ins continued to outperform pre-pandemic levels in October at 109% and 104%, respectively, and followed seasonal patterns.
  • NNN Portfolio (36% of Total Portfolio)
    • NNN sequential same-store (340 assets) cash NOI increased by 0.5% in the third quarter 2021.
  • Office Portfolio (32% of Total Portfolio)
    • Office quarterly same-store pool (335 assets) cash NOI increased by 4.2% versus third quarter 2020 driven by contractual escalators, new leasing and parking recovery. Growth in Medical Office was 3.2% and in Life Science, Research & Innovation (“Life Science, R&I”) was 7.1% versus third quarter 2020.
    • Office sequential same-store pool (335 assets) cash NOI declined by 7.7% versus second quarter 2021 and increased by 1.2% when excluding the impact of a $12 million cash lease termination fee received in the second quarter 2021.

Capital Allocation and Portfolio Strategy

  • Year to date, Ventas has completed or announced $3.7 billion in strategic investments, including $3.1 billion of acquisitions and the $0.5 billion UC Davis life science project. The Company’s current investment priorities are focused on expanding our portfolio of higher-margin senior housing independent living assets in the United States and Canada, growing our Life Science, R&I portfolio and selectively expanding our Medical Office footprint.
    • On September 21, 2021, Ventas closed its acquisition of New Senior in an all-stock transaction for a purchase price of $2.3 billion. This accretive transaction added high quality independent living in advantaged markets with positive supply demand fundamentals while building on existing relationships with experienced leading operators at an attractive valuation below replacement cost. The portfolio consists of 103 independent living communities, with 12,404 units and is located across 36 states.
    • Ventas commenced a Life Science, R&I development anchored by the University of California, Davis, a premier research institution ranked in the top 5% of universities for both NIH funding and R&D spend. The project will be the first phase of Aggie Square, a planned innovation district located on the University’s Sacramento campus and adjacent to UC Davis Medical Center. Developed with Ventas’s exclusive partner, Wexford Science & Technology, the project is principally laboratory space and related uses that will complement existing activities at the UC Davis Health Science Campus, including health sciences research, product development and manufacturing, academic and commercial research, incubator and accelerator space and shared labs. The development will be 60% pre-leased to UC Davis (Moody’s Aa2) and construction is expected to commence in the first half of 2022. Project costs are expected to approximate $0.5 billion with an expected stabilized cash yield exceeding 6%. The development is one of the pre-identified Life Science, R&I development projects in Ventas’s R&I development partnership with GIC.
    • Ventas expanded its relationship with Hawthorn Senior Living through the approximately $180 million acquisition of five independent living and one assisted living communities in Canada. The portfolio consists of five stabilized assets and one lease-up asset. The acquisition price represents a nearly 6% yield on expected stabilized cash NOI and expands Ventas’s presence in the attractive Canadian senior housing sector.
    • Ventas completed the $58 million acquisition of Eating Recovery Center, a 102,000 square foot Class A facility located in Plano, Texas. The asset is 100% net leased with 16 years remaining in the lease term. Eating Recovery Center is a national provider of eating disorder treatments and is a leader in this rapidly growing market. The acquisition price represents a 7.2% GAAP yield on expected 2022 NOI.
    • Ventas, in connection with its long-standing partner Pacific Medical Buildings (“PMB”), completed a buyout of PMB’s interest in the state-of-the-art, newly developed Sutter Van Ness Medical Office Building. The asset is 92% leased and is connected to Sutter Health’s flagship hospital in an unparalleled location in downtown San Francisco. Ventas now owns 100% of this trophy asset at an all-in basis of $173 million or a 5.9% yield on expected 2022 NOI, representing significant expected value creation.
    • Building on and expanding its relationship with Ardent Health Services, Ventas expects to acquire 18 medical office buildings from Ardent comprising 762,000 square feet in a $200 million transaction expected to close in fourth quarter 2021. The portfolio is located in Ardent’s existing markets, over 90% on campus and 100% leased to Ardent with an expected GAAP yield of 5.8%.
    • To position the Company’s senior housing portfolio to benefit from the expected cyclical recovery of senior living, Ventas announced the transition of 90 senior living communities to experienced operators who will provide strong local market focus and oversight for the communities. The transitions are underway, with 65 asset transitions completed and the balance expected to be concluded by the end of 2021.
  • During and subsequent to the third quarter, the Company continues to enhance the quality of its portfolio through asset sales and to receive repayment of high return, well-structured loans. Year to date through November 3, 2021, the Company has received over $875 million of proceeds and remains on track to meet the previously announced guidance of $1 billion in 2021 dispositions.
    • Ventas sold 23 medical office buildings for total consideration of $266 million representing a 5.0% cash yield. Ventas recognized a gain on sale of $113 million in connection with the transactions.
    • Ventas sold a triple-net leased senior housing community in Naples, Florida for approximately $100 million. Ventas recognized a gain on sale of $36 million in connection with the transaction.
    • As previously announced, in the third quarter, Ventas received full repayment of its investment in $200 million of Ardent 9.75% senior notes due 2026, along with a $15 million prepayment premium, and $66 million of Holiday 9.4% notes due 2025.
    • In October, Ventas received full repayment of a $45 million cash pay note bearing 9.5% interest from Brookdale. Ventas originally received the note as part of $235 million of total up-front consideration received in July 2020 as part of mutually beneficial arrangements with Brookdale Senior Living to reset cash rent due to the impact of the pandemic.
    • As of November 3, 2021, Ventas has binding agreements to sell $170 million of senior housing and medical office assets expected to close in 2021.

Financial Strength & Liquidity

  • As of November 3, 2021, the Company has robust liquidity of $2.2 billion, including $2.5 billion of undrawn revolver capacity, net of $0.5 billion of commercial paper outstanding and including $0.2 billion in cash and cash equivalents on hand.
    • For the third quarter 2021, Ventas’s Net Debt to Adjusted Pro Forma EBITDA ratio was 7.2x. The New Senior transaction resulted in an initial 30 basis point leverage increase from 6.9x.
    • During and subsequent to the third quarter, the Company received $593 million in gross proceeds under its “at the market” equity offering program, with 10.3 million shares of common stock sold at an average gross price of $57.74 per share.
    • As previously announced, on August 16, the Company retired $264 million aggregate principal amount of 3.25% senior notes due August 2022 and, on September 1, the Company retired $400 million aggregate principal amount of 3.125% senior notes due June 2023.
    • As of November 3, 2021, the Company has retired $1.1 billion of near-term debt maturities through asset dispositions, loan repayments and other capital sources

Third Quarter Dividend

The Company paid its third quarter 2021 dividend of $0.45 per share on October 14, 2021 to stockholders of record as of October 1, 2021.

Fourth Quarter 2021 Guidance

The Company currently expects to report fourth quarter 2021 Net Income (Loss) Attributable to Common Stockholders, Nareit FFO and Normalized FFO within the following per share ranges:

 

 

4Q21 Guidance

 

 

Per Share

 

 

Low

 

High

 

 

 

 

 

Net Income (Loss) Attributable to Common Stockholders

 

$0.01

-

$0.05

Nareit FFO*

 

$0.61

-

$0.65

Normalized FFO*

 

$0.67

-

$0.71

* This is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure

Key assumptions underlying the fourth quarter 2021 guidance include, among other things:

  • Average occupancy for fourth quarter 2021 in the same-store SHOP business is expected to increase 80 to 120 basis points sequentially, reflecting continued demand exceeding pre-pandemic levels tempered by typical seasonal trends.
  • Revenue for the same-store SHOP business is expected to grow in the fourth quarter as a result of occupancy increases.
  • Approximately stable NOI is expected in the Company’s sequential same-store SHOP business in the fourth quarter. At the mid-point of the range, revenue growth is assumed to be offset by increasing operating costs, notably including continued elevated labor costs.
  • We have assumed that no HHS Grants will be received by the Company in the fourth quarter. Although we have applied for grants under Phase 4 of HHS’s Provider Relief Fund on behalf of the eligible assisted living communities in our SHOP business to mitigate COVID-19 losses, there can be no assurance that our applications will be approved or that our communities will receive any additional funding.
  • Stable sequential performance is expected in the Office and NNN segments.
  • Receipt of a $13 million fee related to the previously announced acquisition of Kindred Healthcare. Kindred has communicated that it expects the transaction to close in the fourth quarter of 2021, subject to receipt of regulatory approvals and satisfaction of customary closing conditions.
  • We have assumed a fully diluted share count of 403 million shares reflecting the equity raised in the third quarter under the Company’s “at the market” equity offering program and shares issued in connection with the New Senior acquisition.
  • The Company continues to expect to receive approximately $1.0 billion in proceeds from asset sales and loan repayments in 2021 principally in senior housing, medical office and loan investments with proceeds used to reduce near-term indebtedness.
  • The guidance assumes no material changes in the impact of COVID-19 on our business. The trajectory and future impact of the COVID-19 pandemic, including the impact of the Delta or any other variant, remain highly uncertain and may change rapidly. The extent of the pandemic’s continuing and ultimate effect on our operational and financial performance will depend on a variety of factors, including the speed at which vaccines and other clinical treatments are successfully developed and deployed. Significant changes or impacts of the pandemic are excluded from our guidance.

Other fourth quarter 2021 assumptions are set forth below:

 

 

Increase / (Decrease) to

Normalized FFO/sh.

4Q21 Guidance Midpoint

vs. 3Q21 Actuals

3Q21 Normalized FFO*

 

$0.73

SHOP

 

(0.00)

Net Tenant Fees

 

(0.01)

Capital Recycling, Debt Reduction & Prefunding Investments

 

(0.02)

Other

 

(0.01)

4Q21 Normalized FFO* Guidance Midpoint

 

$0.69

* This is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.

Investor Presentation

A presentation outlining the Company’s third quarter results and business update is posted to the Events & Presentations section of Ventas’s website at ir.ventasreit.com/events-and-presentations. Additional information regarding the Company can be found in its third quarter 2021 supplemental posted at ir.ventasreit.com. The information contained on, or that may be accessed through, our website is not incorporated by any reference into, and is not part of, this document.

Third Quarter 2021 Results Conference Call

Ventas will hold a conference call to discuss this earnings release on November 5th at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

The dial-in number for the conference call is (833) 968-1984 (or +1 (778) 560-2824 for international callers), and the participant passcode is 8199926. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com.

A telephonic replay will be available at (800) 585-8367 (or +1 (416) 621-4642 for international callers), passcode 8199926, after the earnings call and will remain available for 30 days. The webcast replay will be posted in the Investor Relations section of www.ventasreit.com.

About Ventas

Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, health systems and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.

Non-GAAP Financial Measures

This press release includes certain financial performance measures not defined by generally accepted accounting principles in the Unites States (“GAAP”). Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in this press release. We believe such measures provide investors with additional information concerning our operating performance and a basis to compare our performance with the performance of other REITs. Our definitions and calculations of these non-GAAP measures may not be the same as similar measures reported by other REITs.

These non-GAAP financial measures should not be considered as alternatives to net income attributable to common stockholders (determined in accordance with GAAP) as indicators of our financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of our liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of our needs.

Cautionary Statements

Certain of the information contained herein, including intra-quarter operating information and number of confirmed cases of COVID-19, has been provided by our operators and we have not verified this information through an independent investigation or otherwise. We have no reason to believe that this information is inaccurate in any material respect, but we cannot assure you of its accuracy.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “target,” “forecast,” “plan,” “potential,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof.

Forward-looking statements are based on management’s beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. You are urged to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance in our filings with the Securities and Exchange Commission, including those made in the “Risk Factors” section and “Management’s Discussion & Analysis of Financial Condition and Results of Operations” section of our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made.

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) the impact of the ongoing COVID-19 pandemic, including of the Delta or any other variant, on our revenue, level of profitability, liquidity and overall risk exposure and the implementation and impact of regulations related to the CARES Act and other stimulus legislation and any future COVID-19 relief measures; (b) our ability to achieve the anticipated benefits and synergies from the acquisition of, and the risk of greater than expected costs or other difficulties related to the integration of, New Senior Investment Group Inc.; (c) our exposure and the exposure of our tenants, borrowers and managers to complex healthcare and other regulation and the challenges and expense associated with complying with such regulation; (d) the potential for significant general and commercial claims, legal actions, regulatory proceedings or enforcement actions that could subject us or our tenants, borrowers or managers to increased operating costs and uninsured liabilities; (e) the impact of market and general economic conditions, including economic and financial market events, or events that affect consumer confidence, our occupancy rates and resident fee revenues, and the actual and perceived state of the real estate markets, labor markets and public capital markets; (f) our ability, and the ability of our tenants, borrowers and managers, to navigate the trends impacting our or their businesses and the industries in which we or they operate; (g) the risk of bankruptcy, insolvency or financial deterioration of our tenants, borrowers, managers and other obligors and our ability to foreclose successfully on the collateral securing our loans and other investments in the event of a borrower default; (h) our ability to identify and consummate future investments in or dispositions of healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles; (i) our ability to attract and retain talented employees; (j) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply; (k) the risk of changes in healthcare law or regulation or in tax laws, guidance and interpretations, particularly as applied to REITs, that could adversely affect us or our tenants, borrowers or managers; (l) increases in our borrowing costs as a result of becoming more leveraged or as a result of changes in interest rates and phasing out of LIBOR rates; (m) our reliance on third parties to operate a majority of our assets and our limited control and influence over such operations and results; (n) our dependency on a limited number of tenants and managers for a significant portion of our revenues and operating income; (o) the adequacy of insurance coverage provided by our policies and policies maintained by our tenants, managers or other counterparties; (p) the occurrence of cyber incidents that could disrupt our operations, result in the loss of confidential information or damage our business relationships and reputation; (q) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our tenants, borrowers or managers; and (r) the risk of catastrophic or extreme weather and other natural events and the physical effects of climate change.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts; dollars in USD)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

September 30,

 

June 30,

 

March 31,

 

December 31,

 

September 30,

 

2021

 

2021

 

2021

 

2020

 

2020

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

Real estate investments:

 

 

 

 

 

 

 

 

 

Land and improvements

$

2,395,751

 

 

$

2,231,836

 

 

$

2,235,773

 

 

$

2,261,415

 

 

$

2,268,583

 

Buildings and improvements

25,519,840

 

 

24,269,450

 

 

24,250,630

 

 

24,323,279

 

 

24,196,730

 

Construction in progress

298,982

 

 

288,910

 

 

310,547

 

 

265,748

 

 

567,052

 

Acquired lease intangibles

1,372,462

 

 

1,200,574

 

 

1,212,263

 

 

1,230,886

 

 

1,246,312

 

Operating lease assets

323,950

 

 

328,707

 

 

343,072

 

 

346,372

 

 

386,946

 

 

29,910,985

 

 

28,319,477

 

 

28,352,285

 

 

28,427,700

 

 

28,665,623

 

Accumulated depreciation and amortization

(8,118,990

)

 

(8,189,447

)

 

(8,030,524

)

 

(7,877,665

)

 

(7,687,211

)

Net real estate property

21,791,995

 

 

20,130,030

 

 

20,321,761

 

 

20,550,035

 

 

20,978,412

 

Secured loans receivable and investments, net

530,439

 

 

596,171

 

 

615,037

 

 

605,567

 

 

604,452

 

Investments in unconsolidated real estate entities

507,880

 

 

494,239

 

 

471,243

 

 

443,688

 

 

162,860

 

Net real estate investments

22,830,314

 

 

21,220,440

 

 

21,408,041

 

 

21,599,290

 

 

21,745,724

 

Cash and cash equivalents

143,770

 

 

233,837

 

 

169,661

 

 

413,327

 

 

588,343

 

Escrow deposits and restricted cash

52,752

 

 

40,931

 

 

40,551

 

 

38,313

 

 

40,147

 

Goodwill

1,046,070

 

 

1,051,832

 

 

1,051,780

 

 

1,051,650

 

 

1,050,742

 

Assets held for sale

316,769

 

 

90,002

 

 

59,860

 

 

9,608

 

 

15,748

 

Deferred income tax assets, net

11,496

 

 

11,486

 

 

11,610

 

 

9,987

 

 

304

 

Other assets

643,253

 

 

855,786

 

 

810,760

 

 

807,229

 

 

779,475

 

Total assets

$

25,044,424

 

 

$

23,504,314

 

 

$

23,552,263

 

 

$

23,929,404

 

 

$

24,220,483

 

 

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Senior notes payable and other debt

$

12,078,835

 

 

$

11,761,545

 

 

$

11,759,299

 

 

$

11,895,412

 

 

$

12,047,919

 

Accrued interest

90,013

 

 

105,883

 

 

91,390

 

 

111,444

 

 

97,828

 

Operating lease liabilities

199,551

 

 

205,484

 

 

206,426

 

 

209,917

 

 

247,255

 

Accounts payable and other liabilities

1,142,822

 

 

1,122,171

 

 

1,109,279

 

 

1,133,066

 

 

1,234,933

 

Liabilities related to assets held for sale

20,518

 

 

4,568

 

 

3,853

 

 

3,246

 

 

1,987

 

Deferred income tax liabilities

65,196

 

 

68,097

 

 

65,777

 

 

62,638

 

 

53,711

 

Total liabilities

13,596,935

 

 

13,267,748

 

 

13,236,024

 

 

13,415,723

 

 

13,683,633

 

 

 

 

 

 

 

 

 

 

 

Redeemable OP unitholder and noncontrolling interests

280,344

 

 

252,662

 

 

244,619

 

 

235,490

 

 

249,143

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

 

 

Ventas stockholders’ equity:

 

 

 

 

 

 

 

 

 

Preferred stock, $1.00 par value; 10,000 shares authorized, unissued

 

 

 

 

 

 

 

 

 

Common stock, $0.25 par value; 399,177; 375,204; 375,068; 374,609; and 373,940 shares issued at September 30, 2021, June 30, 2021, March 31, 2021, December 31, 2020, and September 30, 2020, respectively

99,777

 

 

93,784

 

 

93,750

 

 

93,635

 

 

93,467

 

Capital in excess of par value

15,504,210

 

 

14,187,577

 

 

14,186,692

 

 

14,171,262

 

 

14,142,349

 

Accumulated other comprehensive loss

(67,601

)

 

(58,290

)

 

(52,497

)

 

(54,354

)

 

(65,042

)

Retained earnings (deficit)

(4,459,630

)

 

(4,340,052

)

 

(4,257,001

)

 

(4,030,376

)

 

(3,972,647

)

Treasury stock, 1; 6; 14; 0; and 33 shares at September 30, 2021, June 30, 2021, March 31, 2021, December 31, 2020, and September 30, 2020, respectively

(40

)

 

(320

)

 

(789

)

 

 

 

(1,275

)

Total Ventas stockholders’ equity

11,076,716

 

 

9,882,699

 

 

9,970,155

 

 

10,180,167

 

 

10,196,852

 

Noncontrolling interests

90,429

 

 

101,205

 

 

101,465

 

 

98,024

 

 

90,855

 

Total equity

11,167,145

 

 

9,983,904

 

 

10,071,620

 

 

10,278,191

 

 

10,287,707

 

Total liabilities and equity

$

25,044,424

 

 

$

23,504,314

 

 

$

23,552,263

 

 

$

23,929,404

 

 

$

24,220,483

 

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts; dollars in USD)

(unaudited)

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

For the Nine Months Ended

 

September 30,

 

September 30,

 

2021

 

2020

 

2021

 

2020

Revenues

 

 

 

 

 

 

 

Rental income:

 

 

 

 

 

 

 

Triple-net leased

$

181,379

 

 

$

156,136

 

 

$

500,487

 

 

$

527,238

 

Office

201,673

 

 

198,376

 

 

599,516

 

 

599,696

 

 

383,052

 

 

354,512

 

 

1,100,003

 

 

1,126,934

 

Resident fees and services

558,039

 

 

541,322

 

 

1,622,641

 

 

1,667,421

 

Office building and other services revenue

5,841

 

 

3,868

 

 

16,172

 

 

10,669

 

Income from loans and investments

28,729

 

 

18,666

 

 

65,404

 

 

62,203

 

Interest and other income

417

 

 

572

 

 

1,343

 

 

6,965

 

Total revenues

976,078

 

 

918,940

 

 

2,805,563

 

 

2,874,192

 

Expenses

 

 

 

 

 

 

 

Interest

108,816

 

 

115,505

 

 

329,634

 

 

355,333

 

Depreciation and amortization

313,596

 

 

249,366

 

 

878,444

 

 

847,797

 

Property-level operating expenses:

 

 

 

 

 

 

 

Senior living

453,659

 

 

422,653

 

 

1,296,301

 

 

1,265,362

 

Office

66,401

 

 

66,934

 

 

195,297

 

 

192,192

 

Triple-net leased

3,268

 

 

5,398

 

 

12,525

 

 

17,004

 

 

523,328

 

 

494,985

 

 

1,504,123

 

 

1,474,558

 

Office building services costs

522

 

 

557

 

 

1,798

 

 

1,827

 

General, administrative and professional fees

30,259

 

 

32,081

 

 

101,156

 

 

100,621

 

Loss on extinguishment of debt, net

29,792

 

 

7,386

 

 

56,808

 

 

7,386

 

Merger-related expenses and deal costs

22,662

 

 

11,325

 

 

28,000

 

 

26,129

 

Allowance on loans receivable and investments

(60

)

 

4,999

 

 

(9,021

)

 

34,654

 

Other

33,673

 

 

5,681

 

 

10,755

 

 

16,750

 

Total expenses

1,062,588

 

 

921,885

 

 

2,901,697

 

 

2,865,055

 

(Loss) income before unconsolidated entities, real estate

dispositions, income taxes and noncontrolling interests

(86,510

)

 

(2,945

)

 

(96,134

)

 

9,137

 

Income (loss) from unconsolidated entities

2,772

 

 

865

 

 

7,289

 

 

(15,861

)

Gain on real estate dispositions

150,292

 

 

12,622

 

 

194,083

 

 

240,101

 

Income tax (expense) benefit

(3,780

)

 

3,195

 

 

(9,574

)

 

95,855

 

Income from continuing operations

62,774

 

 

13,737

 

 

95,664

 

 

329,232

 

Net income

62,774

 

 

13,737

 

 

95,664

 

 

329,232

 

Net income attributable to noncontrolling interests

2,094

 

 

986

 

 

5,802

 

 

534

 

Net income attributable to common stockholders

$

60,680

 

 

$

12,751

 

 

$

89,862

 

 

$

328,698

 

Earnings per common share

 

 

 

 

 

 

 

Basic:

 

 

 

 

 

 

 

Income from continuing operations

$

0.16

 

 

$

0.04

 

 

$

0.25

 

 

$

0.88

 

Net income attributable to common stockholders

0.16

 

 

0.03

 

 

0.24

 

 

0.88

 

Diluted:

 

 

 

 

 

 

 

Income from continuing operations

$

0.16

 

 

$

0.04

 

 

$

0.25

 

 

$

0.88

 

Net income attributable to common stockholders

0.16

 

 

0.03

 

 

0.24

 

 

0.87

 

 

 

 

 

 

 

 

 

Weighted average shares used in computing earnings per common share

 

 

 

 

 

 

 

Basic

381,996

 

 

373,177

 

 

377,271

 

 

372,997

 

Diluted

385,523

 

 

376,295

 

 

380,643

 

 

376,112

 

QUARTERLY CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts; dollars in USD)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

September 30,

 

June 30,

 

March 31,

 

December 31,

 

September 30,

 

2021

 

2021

 

2021

 

2020

 

2020

Revenues

 

 

 

 

 

 

 

 

 

Rental income:

 

 

 

 

 

 

 

 

 

Triple-net leased

$

181,379

 

 

$

159,223

 

 

$

159,885

 

 

$

168,027

 

 

$

156,136

 

Office

201,673

 

 

200,388

 

 

197,455

 

 

199,931

 

 

198,376

 

 

383,052

 

 

359,611

 

 

357,340

 

 

367,958

 

 

354,512

 

Resident fees and services

558,039

 

 

535,952

 

 

528,650

 

 

529,739

 

 

541,322

 

Office building and other services revenue

5,841

 

 

5,381

 

 

4,950

 

 

4,522

 

 

3,868

 

Income from loans and investments

28,729

 

 

17,665

 

 

19,010

 

 

18,302

 

 

18,666

 

Interest and other income

417

 

 

585

 

 

341

 

 

644

 

 

572

 

Total revenues

976,078

 

 

919,194

 

 

910,291

 

 

921,165

 

 

918,940

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

Interest

108,816

 

 

110,051

 

 

110,767

 

 

114,208

 

 

115,505

 

Depreciation and amortization

313,596

 

 

250,700

 

 

314,148

 

 

261,966

 

 

249,366

 

Property-level operating expenses:

 

 

 

 

 

 

 

 

 

Senior living

453,659

 

 

424,813

 

 

417,829

 

 

393,309

 

 

422,653

 

Office

66,401

 

 

64,950

 

 

63,946

 

 

64,420

 

 

66,934

 

Triple-net leased

3,268

 

 

4,432

 

 

4,825

 

 

5,156

 

 

5,398

 

 

523,328

 

 

494,195

 

 

486,600

 

 

462,885

 

 

494,985

 

Office building services costs

522

 

 

658

 

 

618

 

 

488

 

 

557

 

General, administrative and professional fees

30,259

 

 

30,588

 

 

40,309

 

 

29,537

 

 

32,081

 

Loss (gain) on extinguishment of debt, net

29,792

 

 

(74

)

 

27,090

 

 

3,405

 

 

7,386

 

Merger-related expenses and deal costs

22,662

 

 

721

 

 

4,617

 

 

3,683

 

 

11,325

 

Allowance on loans receivable and investments

(60

)

 

(59

)

 

(8,902

)

 

(10,416

)

 

4,999

 

Other

33,673

 

 

(13,490

)

 

(9,428

)

 

(16,043

)

 

5,681

 

Total expenses

1,062,588

 

 

873,290

 

 

965,819

 

 

849,713

 

 

921,885

 

 

 

 

 

 

 

 

 

 

 

(Loss) income before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests

(86,510

)

 

45,904

 

 

(55,528

)

 

71,452

 

 

(2,945

)

Income (loss) from unconsolidated entities

2,772

 

 

4,767

 

 

(250

)

 

17,705

 

 

865

 

Gain on real estate dispositions

150,292

 

 

41,258

 

 

2,533

 

 

22,117

 

 

12,622

 

Income tax (expense) benefit

(3,780

)

 

(3,641

)

 

(2,153

)

 

679

 

 

3,195

 

Income (loss) from continuing operations

62,774

 

 

88,288

 

 

(55,398

)

 

111,953

 

 

13,737

 

Net income (loss)

62,774

 

 

88,288

 

 

(55,398

)

 

111,953

 

 

13,737

 

Net income attributable to noncontrolling interests

2,094

 

 

1,897

 

 

1,811

 

 

1,502

 

 

986

 

Net income (loss) attributable to common stockholders

$

60,680

 

 

$

86,391

 

 

$

(57,209

)

 

$

110,451

 

 

$

12,751

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share

 

 

 

 

 

 

 

 

 

Basic:

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations

$

0.16

 

 

$

0.24

 

 

$

(0.15

)

 

$

0.30

 

 

$

0.04

 

Net income (loss) attributable to common stockholders

0.16

 

 

0.23

 

 

(0.15

)

 

0.29

 

 

0.03

 

Diluted:1

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations

$

0.16

 

 

$

0.23

 

 

$

(0.15

)

 

$

0.30

 

 

$

0.04

 

Net income (loss) attributable to common stockholders

0.16

 

 

0.23

 

 

(0.15

)

 

0.29

 

 

0.03

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares used in computing earnings per common share

 

 

 

 

 

 

 

 

 

Basic

381,996

 

 

375,067

 

 

374,669

 

 

374,473

 

 

373,177

 

Diluted

385,523

 

 

378,408

 

 

377,922

 

 

377,696

 

 

376,295

 

 

 

 

 

 

 

 

 

 

 

1 Potential common shares are not included in the computation of diluted earnings per share when a loss from continuing operations exists as the effect would be an antidilutive per share amount.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands USD)

(unaudited)

 

For the Nine Months Ended September 30,

 

2021

 

2020

Cash flows from operating activities:

 

 

 

Net income

$

95,664

 

 

$

329,232

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

878,444

 

 

847,797

 

Amortization of deferred revenue and lease intangibles, net

(71,620

)

 

(25,343

)

Other non-cash amortization

14,686

 

 

15,211

 

Allowance on loans receivable and investments

(9,021

)

 

34,654

 

Stock-based compensation

26,165

 

 

17,322

 

Straight-lining of rental income

(10,166

)

 

107,134

 

Loss on extinguishment of debt, net

56,808

 

 

7,386

 

Gain on real estate dispositions

(194,083

)

 

(240,101

)

Gain on real estate loan investments

(2,006

)

 

(167

)

Income tax expense (benefit)

4,656

 

 

(99,702

)

(Income) loss from unconsolidated entities

(7,279

)

 

15,869

 

Distributions from unconsolidated entities

9,466

 

 

2,960

 

Other

(830

)

 

15,615

 

Changes in operating assets and liabilities:

 

 

 

Increase in other assets

(49,051

)

 

(68,228

)

Decrease in accrued interest

(22,414

)

 

(12,975

)

Increase in accounts payable and other liabilities

40,896

 

 

207,749

 

Net cash provided by operating activities

760,315

 

 

1,154,413

 

Cash flows from investing activities:

 

 

 

Net investment in real estate property

(1,103,210

)

 

(77,625

)

Investment in loans receivable

(384

)

 

(113,147

)

Proceeds from real estate disposals

497,303

 

 

682,604

 

Proceeds from loans receivable

302,700

 

 

106,966

 

Development project expenditures

(204,649

)

 

(309,967

)

Capital expenditures

(119,311

)

 

(94,407

)

Distributions from unconsolidated entities

17,847

 

 

 

Investment in unconsolidated entities

(107,140

)

 

(7,832

)

Insurance proceeds for property damage claims

501

 

 

33

 

Net cash (used in) provided by investing activities

(716,343

)

 

186,625

 

Cash flows from financing activities:

 

 

 

Net change in borrowings under revolving credit facilities

(144,065

)

 

(74,144

)

Net change in borrowings under commercial paper program

369,943

 

 

(565,524

)

Proceeds from debt

914,879

 

 

657,557

 

Repayment of debt

(1,499,036

)

 

(127,528

)

Purchase of noncontrolling interests

(11,485

)

 

 

Payment of deferred financing costs

(23,608

)

 

(7,564

)

Issuance of common stock, net

617,438

 

 

36,395

 

Cash distribution to common stockholders

(506,972

)

 

(760,363

)

Cash distribution to redeemable OP unitholders

(5,400

)

 

(5,954

)

Cash issued for redemption of OP Units

(96

)

 

(575

)

Contributions from noncontrolling interests

35

 

 

1,138

 

Distributions to noncontrolling interests

(11,785

)

 

(9,666

)

Proceeds from stock option exercises

5,668

 

 

3,518

 

Other

(5,128

)

 

(4,989

)

Net cash used in financing activities

(299,612

)

 

(857,699

)

Net (decrease) increase in cash, cash equivalents and restricted cash

(255,640

)

 

483,339

 

Effect of foreign currency translation

522

 

 

(951

)

Cash, cash equivalents and restricted cash at beginning of period

451,640

 

 

146,102

 

Cash, cash equivalents and restricted cash at end of period

$

196,522

 

 

$

628,490

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Nine Months Ended September 30,

 

2021

 

2020

Supplemental schedule of non-cash activities:

 

 

 

Assets acquired and liabilities assumed from acquisitions and other:

 

 

 

Real estate investments

$

1,317,617

 

 

$

169,484

 

Other assets

16,132

 

 

1,224

 

Debt

484,073

 

 

55,368

 

Other liabilities

97,960

 

 

2,707

 

Deferred income tax liability

 

 

337

 

Noncontrolling interests

468

 

 

20,259

 

Equity issued

751,248

 

 

 

Equity issued for redemption of OP Units

76

 

 

 

QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands USD)

(unaudited)

 

For the Three Months Ended

 

September 30,

 

June 30,

 

March 31,

 

December 31,

 

September 30,

 

2021

 

2021

 

2021

 

2020

 

2020

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net income (loss)

$

62,774

 

 

$

88,288

 

 

$

(55,398

)

 

$

111,953

 

 

$

13,737

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

313,596

 

 

250,700

 

 

314,148

 

 

261,966

 

 

249,366

 

Amortization of deferred revenue and lease intangibles, net

(40,069

)

 

(16,785

)

 

(14,766

)

 

(15,513

)

 

(19,009

)

Other non-cash amortization

4,567

 

 

4,847

 

 

5,272

 

 

5,508

 

 

5,558

 

Allowance on loans receivable and investments

(60

)

 

(59

)

 

(8,902

)

 

(10,416

)

 

4,999

 

Stock-based compensation

4,700

 

 

5,393

 

 

16,072

 

 

4,165

 

 

5,765

 

Straight-lining of rental income

(2,999

)

 

(3,304

)

 

(3,863

)

 

(4,052

)

 

15,635

 

Loss (gain) on extinguishment of debt, net

29,792

 

 

(74

)

 

27,090

 

 

3,405

 

 

7,386

 

Gain on real estate dispositions

(150,292

)

 

(41,258

)

 

(2,533

)

 

(22,117

)

 

(12,622

)

Gain on real estate loan investments

(1,932

)

 

 

 

(74

)

 

 

 

 

Income tax expense (benefit)

2,146

 

 

2,007

 

 

503

 

 

(2,283

)

 

(4,575

)

(Income) loss from unconsolidated entities

(2,767

)

 

(4,762

)

 

250

 

 

(17,701

)

 

(865

)

Distributions from unconsolidated entities

2,986

 

 

2,583

 

 

3,897

 

 

1,960

 

 

1,360

 

Other

34,011

 

 

(20,462

)

 

(14,379

)

 

(16,394

)

 

2,859

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

(Increase) decrease in other assets

(23,433

)

 

(20,518

)

 

(5,100

)

 

(5

)

 

(55,765

)

(Decrease) increase in accrued interest

(16,682

)

 

14,502

 

 

(20,234

)

 

13,251

 

 

(20,069

)

Increase (decrease) in accounts payable and other liabilities

15,121

 

 

30,165

 

 

(4,390

)

 

(17,964

)

 

240,642

 

Net cash provided by operating activities

231,459

 

 

291,263

 

 

237,593

 

 

295,763

 

 

434,402

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Net investment in real estate property

(1,103,000

)

 

 

 

(210

)

 

(1,023

)

 

(156

)

Investment in loans receivable

(101

)

 

(97

)

 

(186

)

 

(2,016

)

 

(45,857

)

Proceeds from real estate disposals

381,453

 

 

107,767

 

 

8,083

 

 

361,753

 

 

54,800

 

Proceeds from loans receivable

266,225

 

 

20,056

 

 

16,419

 

 

12,045

 

 

191

 

Development project expenditures

(73,755

)

 

(72,296

)

 

(58,598

)

 

(70,446

)

 

(129,569

)

Capital expenditures

(45,189

)

 

(44,448

)

 

(29,674

)

 

(53,827

)

 

(40,888

)

Distributions from unconsolidated entities

17,847

 

 

 

 

 

 

 

 

 

Investment in unconsolidated entities

(38,829

)

 

(29,859

)

 

(38,452

)

 

(278,990

)

 

33

 

Insurance proceeds (expense) for property damage claims

111

 

 

384

 

 

6

 

 

174

 

 

(9

)

Net cash used in investing activities

(595,238

)

 

(18,493

)

 

(102,612

)

 

(32,330

)

 

(161,455

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Net change in borrowings under revolving credit facilities

(39,934

)

 

(109,275

)

 

5,144

 

 

(14,724

)

 

(539,560

)

Net change in borrowings under commercial paper program

199,959

 

 

(44,994

)

 

214,978

 

 

 

 

 

Proceeds from debt

646,593

 

 

237,129

 

 

31,157

 

 

75,741

 

 

17,024

 

Repayment of debt

(933,085

)

 

(120,901

)

 

(445,050

)

 

(352,011

)

 

(16,227

)

Purchase of noncontrolling interests

(11,485

)

 

 

 

 

 

(8,239

)

 

 

Payment of deferred financing costs

(5,832

)

 

(433

)

 

(17,343

)

 

(815

)

 

(15

)

Issuance of common stock, net

603,188

 

 

3,175

 

 

11,075

 

 

18,967

 

 

36,395

 

Cash distribution to common stockholders

(169,134

)

 

(169,075

)

 

(168,763

)

 

(168,446

)

 

(168,078

)

Cash distribution to redeemable OP unitholders

(2,236

)

 

(1,322

)

 

(1,842

)

 

(1,329

)

 

(1,326

)

Cash issued for redemption of OP Units

(34

)

 

(37

)

 

(25

)

 

 

 

(5

)

Contributions from noncontrolling interests

5

 

 

25

 

 

5

 

 

176

 

 

792

 

Distributions to noncontrolling interests

(3,197

)

 

(5,935

)

 

(2,653

)

 

(3,280

)

 

(3,373

)

Proceeds from stock option exercises

847

 

 

2,715

 

 

2,106

 

 

11,585

 

 

 

Other

806

 

 

(78

)

 

(5,856

)

 

53

 

 

(98

)

Net cash provided by (used in) financing activities

286,461

 

 

(209,006

)

 

(377,067

)

 

(442,322

)

 

(674,471

)

Net (decrease) increase in cash, cash equivalents and restricted cash

(77,318

)

 

63,764

 

 

(242,086

)

 

(178,889

)

 

(401,524

)

Effect of foreign currency translation

(928

)

 

792

 

 

658

 

 

2,039

 

 

878

 

Cash, cash equivalents and restricted cash at beginning of period

274,768

 

 

210,212

 

 

451,640

 

 

628,490

 

 

1,029,136

 

Cash, cash equivalents and restricted cash at end of period

$

196,522

 

 

$

274,768

 

 

$

210,212

 

 

$

451,640

 

 

$

628,490

 

QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(Dollars in thousands USD)

(unaudited)

 

For the Three Months Ended

 

September 30,

 

June 30,

 

March 31,

 

December 31,

 

September 30,

 

2021

 

2021

 

2021

 

2020

 

2020

Supplemental schedule of non-cash activities:

 

 

 

 

 

 

 

 

 

Assets acquired and liabilities assumed from acquisitions and other:

 

 

 

 

 

 

 

 

 

Real estate investments

$

1,317,149

 

 

$

 

 

$

468

 

 

$

1,000

 

 

$

92,373

 

Other assets

16,132

 

 

 

 

 

 

 

 

610

 

Debt

484,073

 

 

 

 

 

 

 

 

 

Other liabilities

97,960

 

 

 

 

 

 

 

 

610

 

Deferred income tax liability

 

 

 

 

 

 

 

 

337

 

Noncontrolling interests

 

 

 

 

468

 

 

 

 

 

Equity issued

751,248

 

 

 

 

 

 

 

 

 

Equity issued for redemption of OP Units

76

 

 

 

 

 

 

 

 

 

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Funds From Operations Attributable to Common Stockholders (FFO)1

and Funds Available for Distribution Attributable to Common Stockholders (FAD)1

(In thousands, except per share amounts; dollars in USD)

(unaudited)

 

 

 

 

 

 

 

 

 

Q3 YoY

 

 

 

 

2020

 

2021

 

Growth

 

 

 

 

Q3

Q4

 

Q1

Q2

Q3

 

’20-’21

 

YTD 3Q20

YTD 3Q21

Net income (loss) attributable to common stockholders

$

12,751

 

$

110,451

 

 

$

(57,209

)

$

86,391

 

$

60,680

 

 

376

%

 

$

328,698

 

$

89,862

 

Net income (loss) attributable to common stockholders per share2

$

0.03

 

$

0.29

 

 

$

(0.15

)

$

0.23

 

$

0.16

 

 

433

%

 

$

0.87

 

$

0.24

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization on real estate assets

247,969

 

260,705

 

 

312,869

 

249,527

 

312,524

 

 

 

 

843,409

 

874,920

 

Depreciation on real estate assets related to noncontrolling interests

(4,475

)

(4,381

)

 

(4,618

)

(4,678

)

(4,641

)

 

 

 

(12,386

)

(13,937

)

Depreciation on real estate assets related to unconsolidated entities

1,360

 

1,758

 

 

4,018

 

4,615

 

4,474

 

 

 

 

3,228

 

13,107

 

Gain on real estate dispositions

(12,622

)

(22,117

)

 

(2,533

)

(41,258

)

(150,292

)

 

 

 

(240,101

)

(194,083

)

(Loss) gain on real estate dispositions related to noncontrolling interests

 

 

 

 

(7

)

232

 

 

 

 

(9

)

225

 

Subtotal: FFO adjustments

232,232

 

235,965

 

 

309,736

 

208,199

 

162,297

 

 

 

 

594,141

 

680,232

 

Subtotal: FFO adjustments per share

$

0.62

 

$

0.62

 

 

$

0.82

 

$

0.55

 

$

0.42

 

 

 

 

$

1.58

 

$

1.79

 

FFO (Nareit) attributable to common stockholders

$

244,983

 

$

346,416

 

 

$

252,527

 

$

294,590

 

$

222,977

 

 

(9

%)

 

$

922,839

 

$

770,094

 

FFO (Nareit) attributable to common stockholders per share

$

0.65

 

$

0.92

 

 

$

0.67

 

$

0.78

 

$

0.58

 

 

(11

%)

 

$

2.45

 

$

2.02

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of financial instruments

1,157

 

(23,062

)

 

(21,008

)

(23,211

)

25,451

 

 

 

 

1,134

 

(18,768

)

Non-cash income tax (benefit) expense

(4,763

)

(7,961

)

 

1,344

 

1,166

 

2,146

 

 

 

 

(90,153

)

4,656

 

Loss (gain) on extinguishment of debt, net

7,386

 

3,405

 

 

27,090

 

(74

)

34,654

 

 

 

 

7,386

 

61,670

 

Gain on transactions related to unconsolidated entities

(244

)

(592

)

 

(21

)

(10

)

(8,808

)

 

 

 

(5

)

(8,839

)

Merger-related expenses, deal costs and re-audit costs

12,793

 

6,519

 

 

5,360

 

1,769

 

25,531

 

 

 

 

28,171

 

32,660

 

Amortization of other intangibles

118

 

118

 

 

116

 

116

 

(22,085

)

 

 

 

354

 

(21,853

)

Other items related to unconsolidated entities

290

 

234

 

 

101

 

43

 

987

 

 

 

 

(848

)

1,131

 

Non-cash impact of changes to equity plan

(1,923

)

(2,087

)

 

8,741

 

(2,298

)

(2,359

)

 

 

 

1,635

 

4,084

 

Natural disaster expenses (recoveries), net

125

 

(71

)

 

5,127

 

3,128

 

1,552

 

 

 

 

1,318

 

9,807

 

Impact of Holiday lease termination

 

 

 

 

 

 

 

 

 

(50,184

)

 

Write-off of straight-line rental income, net of noncontrolling interests

18,408

 

87

 

 

 

 

 

 

 

 

70,776

 

 

Allowance on loan investments and impairment of unconsolidated entities, net of

noncontrolling interests

4,635

 

(10,412

)

 

(8,900

)

(57

)

(58

)

 

 

 

44,955

 

(9,015

)

Subtotal: Normalized FFO adjustments

37,982

 

(33,822

)

 

17,950

 

(19,428

)

57,011

 

 

 

 

14,539

 

55,533

 

Subtotal: Normalized FFO adjustments per share

$

0.10

 

$

(0.09

)

 

$

0.05

 

$

(0.05

)

$

0.15

 

 

 

 

$

0.04

 

$

0.15

 

Normalized FFO attributable to common stockholders

$

282,965

 

$

312,594

 

 

$

270,477

 

$

275,162

 

$

279,988

 

 

(1

%)

 

$

937,378

 

$

825,627

 

Normalized FFO attributable to common stockholders per share

$

0.75

 

$

0.83

 

 

$

0.72

 

$

0.73

 

$

0.73

 

 

(3

%)

 

$

2.49

 

$

2.17

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue and lease intangibles, net

(19,009

)

(15,513

)

 

(14,766

)

(14,779

)

(14,182

)

 

 

 

(25,344

)

(43,727

)

Other non-cash amortization, including fair market value of debt

5,558

 

5,508

 

 

5,272

 

4,847

 

4,567

 

 

 

 

15,212

 

14,686

 

Stock-based compensation

7,688

 

6,252

 

 

7,331

 

7,691

 

7,059

 

 

 

 

15,687

 

22,081

 

Straight-lining of rental income

(4,648

)

(4,052

)

 

(3,863

)

(3,304

)

(3,567

)

 

 

 

(16,962

)

(10,734

)

FAD Capital Expenditures

(39,955

)

(52,645

)

 

(28,506

)

(42,651

)

(42,393

)

 

 

 

(91,029

)

(113,550

)

Subtotal: Operating FAD adjustments

(50,366

)

(60,450

)

 

(34,532

)

(48,196

)

(48,516

)

 

 

 

(102,436

)

(131,244

)

Operating FAD attributable to common stockholders 3

$

232,599

 

$

252,144

 

 

$

235,945

 

$

226,966

 

$

231,472

 

 

0

%

 

$

834,942

 

$

694,383

 

Merger-related expenses, deal costs and re-audit costs

(12,793

)

(6,519

)

 

(5,360

)

(1,769

)

(25,531

)

 

 

 

(28,171

)

(32,660

)

Other items related to unconsolidated entities

(290

)

(234

)

 

(101

)

(43

)

(987

)

 

 

 

848

 

(1,131

)

FAD attributable to common stockholders 3

$

219,516

 

$

245,391

 

 

$

230,484

 

$

225,154

 

$

204,954

 

 

(7

%)

 

$

807,619

 

$

660,592

 

Weighted average diluted shares

376,295

 

377,696

 

 

377,922

 

378,408

 

385,523

 

 

 

 

376,112

 

380,643

 

 

 

 

 

 

 

 

 

 

 

 

 

1 Per share quarterly amounts may not add to annual per share amounts due to material changes in the Company’s weighted average diluted share count, if any. Per share amounts may not add to total per share amounts due to rounding.

2 Potential common shares are not included in the computation of diluted earnings per share when a loss from continuing operations exists as the effect would be an antidilutive per share amount.

3 Operating FAD and FAD exclude the impact of the Company’s receipt of unusually significant amounts of cash in connection with lease terminations and modifications. Exclusions in the period presented are $34 million in cash received in April 2020 related to the Holiday lease termination and $162 million in cash received in July 2020 related to the Brookdale lease modification. For additional information related to these transactions, refer to the Company’s earnings release and Form 10-Q for the quarter ended September 30, 2020.

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Net Income and FFO Attributable to Common Stockholders Q4 2021 Guidance1,2

(In millions, except per share amounts; dollars in USD)

(unaudited)

 

 

 

Q4 2021 Guidance

 

 

Tentative / Preliminary and Subject to Change

 

 

Q4 2021

 

Q4 2021 - Per Share

 

 

Low

 

High

 

Low

 

High

 

 

 

 

 

 

 

 

 

Net Income Attributable to Common Stockholders

 

$

4

 

 

$

20

 

 

$

0.01

 

 

$

0.05

 

 

 

 

 

 

 

 

 

 

Depreciation & Amortization Adjustments

 

 

267

 

 

 

267

 

 

 

0.66

 

 

 

0.66

 

Gain on Real Estate Dispositions

 

 

(24

)

 

 

(24

)

 

 

(0.06

)

 

 

(0.06

)

Other Adjustments 3

 

 

 

 

 

 

 

 

0.00

 

 

 

0.00

 

 

 

 

 

 

 

 

 

 

FFO (Nareit) Attributable to Common Stockholders

 

$

247

 

 

$

262

 

 

$

0.61

 

 

$

0.65

 

 

 

 

 

 

 

 

 

 

Merger-Related Expenses, Deal Costs & Re-Audit Costs

 

 

20

 

 

 

23

 

 

 

0.05

 

 

 

0.06

 

Other Adjustments 3

 

 

3

 

 

 

1

 

 

 

0.01

 

 

 

0.00

 

 

 

 

 

 

 

 

 

 

Normalized FFO Attributable to Common Stockholders

 

$

270

 

 

$

286

 

 

$

0.67

 

 

$

0.71

 

% Year-Over-Year Growth

 

 

 

 

 

 

(19

%)

 

 

(14

%)

 

 

 

 

 

 

 

 

 

Weighted Average Diluted Shares (in millions)

 

 

403

 

 

 

403

 

 

 

 

 

1

The Company’s guidance constitutes forward looking statements within the meaning of the federal securities laws and is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. Actual results may differ materially from the Company's expectations depending on factors discussed herein and in the Company’s filings with the Securities and Exchange Commission.

 

2

Per share quarterly amounts may not add to annual per share amounts due to changes in the Company’s weighted average diluted share count, if any.

 

3

Other Adjustments include the categories of adjustments presented in our “Non-GAAP Financial Measures Reconciliation – Funds From Operations Attributable to Common Stockholders (FFO) and Funds Available for Distribution Attributable to Common Stockholders (FAD)” above.

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, since real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, the Company considers FFO, Normalized FFO, FAD and Operating FAD to be appropriate supplemental measures of operating performance of an equity REIT. The Company believes that the presentation of FFO, combined with the presentation of required GAAP financial measures, has improved the understanding of operating results of REITs among the investing public and has helped make comparisons of REIT operating results more meaningful. Management generally considers FFO to be a useful measure for understanding and comparing our operating results because, by excluding gains and losses related to sales of previously depreciated operating real estate assets, impairment losses on depreciable real estate and real estate asset depreciation and amortization (which can differ across owners of similar assets in similar condition based on historical cost accounting and useful life estimates), FFO can help investors compare the operating performance of a company’s real estate across reporting periods and to the operating performance of other companies. The Company believes that Normalized FFO is useful because it allows investors, analysts and Company management to compare the Company’s operating performance to the operating performance of other real estate companies and between periods on a consistent basis without having to account for differences caused by non-recurring items and other non-operational events such as transactions and litigation. In some cases, the Company provides information about identified non-cash components of FFO and Normalized FFO because it allows investors, analysts and Company management to assess the impact of those items on the Company’s financial results. Further, the Company believes that FAD and Operating FAD are useful supplemental measures of the Company’s operating performance that would not otherwise be available and may be useful to investors in assessing the Company’s operating performance and performance as a REIT. The Company believes FAD and Operating FAD may provide investors with useful supplemental information regarding the Company’s ability to generate income from its operating performance and the impact of the Company’s operating performance on its ability to make distributions to its stockholders.

The Company uses the National Association of Real Estate Investment Trusts (“Nareit”) definition of FFO. Nareit defines FFO as net income attributable to common stockholders (computed in accordance with GAAP), excluding gains or losses from sales of real estate property, including gains or losses on re-measurement of equity method investments, and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and entities. Adjustments for unconsolidated partnerships and entities will be calculated to reflect FFO on the same basis. The Company defines Normalized FFO as FFO excluding the following income and expense items (which may be recurring in nature): (a) merger-related costs and expenses, including amortization of intangibles, transition and integration expenses, and deal costs and expenses, including expenses and recoveries relating to acquisition lawsuits; (b) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of the Company’s debt; (c) the non-cash effect of income tax benefits or expenses, the non-cash impact of changes to the Company’s executive equity compensation plan, derivative transactions that have non-cash mark to market impacts on the Company’s income statement and non-cash charges related to leases; (d) the financial impact of contingent consideration, severance-related costs and charitable donations made to the Ventas Charitable Foundation; (e) gains and losses for non-operational foreign currency hedge agreements and changes in the fair value of financial instruments; (f) gains and losses on non-real estate dispositions and other unusual items related to unconsolidated entities; (g) expenses related to the re-audit and re-review in 2014 of the Company’s historical financial statements and related matters; (h) net expenses or recoveries related to natural disasters and (i) any other incremental items set forth in the Normalized FFO reconciliation included herein.

Operating FAD represents Normalized FFO (i) excluding non-cash components and straight-line rent adjustments and (ii) including the impact of FAD Capital Expenditures. FAD Capital Expenditures are (i) Ventas-invested capital expenditures, whether routine or non-routine, that extend the useful life of a property but are not expected to generate incremental income for the Company (ii) Office Building and Triple-Net leasing commissions paid to third-party agents and (iii) capital expenditures for second-generation tenant improvements. It excludes (i) costs for a first generation lease (e.g., a development project) or related to properties that have undergone redevelopment and (ii) Initial Capital Expenditures, which are defined as capital expenditures required to bring a newly acquired or newly transitioned property up to standard. Initial Capital Expenditures are typically incurred within the first 12 months after acquisition or transition, respectively.

FAD represents Operating FAD after including the impact of deal costs and unusual items related to unconsolidated entities.

FFO, Normalized FFO, FAD and Operating FAD presented herein may not be comparable to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. FFO, Normalized FFO, FAD and Operating FAD should not be considered as alternatives to net income attributable to common stockholders (determined in accordance with GAAP) as indicators of the Company’s financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company’s liquidity, nor are they necessarily indicative of sufficient cash flow to fund all of the Company’s needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, FFO, Normalized FFO, FAD and Operating FAD should be examined in conjunction with net income attributable to common stockholders as presented elsewhere herein.

 

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Net Debt to Adjusted Pro Forma EBITDA1

(Dollars in thousands USD)

(unaudited)

 

 

 

For the Three Months

Ended September 30,

2021

 

 

 

Net income attributable to common stockholders

 

$

60,680

 

Adjustments:

 

 

Interest

 

108,816

 

Loss on extinguishment of debt, net

 

29,792

 

Taxes (including tax amounts in general, administrative and professional fees)

 

5,151

 

Depreciation and amortization

 

313,596

 

Non-cash stock-based compensation expense

 

4,700

 

Merger-related expenses, deal costs and re-audit costs

 

22,662

 

Net income attributable to noncontrolling interests, adjusted for partners’ share of consolidated entity EBITDA

 

(6,578

)

Loss from unconsolidated entities, adjusted for Ventas share of EBITDA from unconsolidated entities

 

14,002

 

Gain on real estate dispositions

 

(150,292

)

Unrealized foreign currency loss

 

33

 

Change in fair value of financial instruments

 

25,448

 

Natural disaster expenses, net

 

1,566

 

Allowance on loan investments, net of noncontrolling interests

 

(58

)

Adjusted EBITDA

 

$

429,518

 

Adjustments for New Senior acquisition2

 

24,698

 

Adjustments for current period activity

 

(41,268

)

Adjusted Pro Forma EBITDA

 

$

412,948

 

 

 

 

Adjusted Pro Forma EBITDA annualized

 

$

1,651,792

 

 

 

 

 

 

 

Total debt

 

$

12,078,835

 

Cash

 

(143,770

)

Restricted cash pertaining to debt

 

(23,515

)

Partners’ share of consolidated debt

 

(277,325

)

Ventas share of non-consolidated debt

 

292,516

 

Net debt

 

$

11,926,741

 

 

 

 

Net debt to Adjusted Pro Forma EBITDA

 

7.2

x

 

 

 

1 Totals may not add due to rounding.

 

2 On September 21, 2021, Ventas acquired New Senior Investment Group. New Senior’s financial results following the acquisition are included in Adjusted EBITDA for the three months ended September 30, 2021. New Senior’s financial results prior to the acquisition, as adjusted to reflect anticipated G&A synergies that are directly attributable to the acquisition, are included in Adjusted Pro Forma EBITDA for the three months ended September 30, 2021. New Senior’s financial results prior to the acquisition were derived from New Senior’s accounting records. Anticipated G&A synergies reflected in Adjusted Pro Forma EBITDA are based on preliminary estimates and assumptions, which are subject to change. For additional information related to the acquisition of New Senior, please refer to Ventas’s earnings release and Form 10-Q for the quarter ended September 30, 2021.

The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization (including non-cash stock-based compensation expense, asset impairment and valuation allowances), excluding gains or losses on extinguishment of debt, partners’ share of EBITDA of consolidated entities, merger-related expenses and deal costs, expenses related to the re-audit and re-review in 2014 of the Company’s historical financial statements, net gains or losses on real estate activity, gains or losses on re-measurement of equity interest upon acquisition, changes in the fair value of financial instruments, unrealized foreign currency gains or losses, net expenses or recoveries related to natural disasters and non-cash charges related to leases, and including (a) Ventas’ share of EBITDA from unconsolidated entities and (b) other immaterial or identified items.

The information above considers the pro forma effect on Adjusted EBITDA of the Company’s activity during the three months ended September 30, 2021, as if the transactions had been consummated as of the beginning of the period (“Adjusted Pro Forma EBITDA”) and considers any other incremental items set forth in the Adjusted Pro Forma EBITDA reconciliation included herein.

The Company believes that Net debt, Adjusted Pro Forma EBITDA and Net debt to Adjusted Pro Forma EBITDA are useful to investors, analysts and Company management because they allow the comparison of the Company’s credit strength between periods and to other real estate companies without the effect of items that by their nature are not comparable from period to period.

 

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Net Operating Income (NOI) and Same-Store Cash NOI by Segment (Constant Currency)

(Dollars in thousands USD)

(unaudited)

For the Three Months Ended September 30, 2021 and 2020

 

Triple-Net

Senior Housing

Operating

Office

Non-Segment

Total

For the Three Months Ended September 30, 2021

Net income attributable to common stockholders

 

 

 

 

$

60,680

 

Adjustments:

 

 

 

 

 

Interest and other income

 

 

 

 

(417

)

Interest expense

 

 

 

 

108,816

 

Depreciation and amortization

 

 

 

 

313,596

 

General, administrative and professional fees

 

 

 

 

30,259

 

Loss on extinguishment of debt, net

 

 

 

 

29,792

 

Merger-related expenses and deal costs

 

 

 

 

22,662

 

Allowance on loans receivable and investments

 

 

 

 

(60

)

Other

 

 

 

 

33,673

 

Income from unconsolidated entities

 

 

 

 

(2,772

)

Gain on real estate dispositions

 

 

 

 

(150,292

)

Income tax expense

 

 

 

 

3,780

 

Net income attributable to noncontrolling interests

 

 

 

 

2,094

 

Reported segment NOI

$

178,111

 

$

104,380

 

$

137,622

 

$

31,698

 

$

451,811

 

Adjustments:

 

 

 

 

 

Straight-lining of rental income

(1,854

)

 

(1,713

)

 

(3,567

)

Non-cash rental income

(11,713

)

 

(5,491

)

 

(17,204

)

Non-cash impact of lease termination

(22,309

)

 

 

 

(22,309

)

NOI not included in cash NOI1

(2,065

)

(216

)

(5,927

)

 

(8,208

)

Non-segment NOI

 

 

 

(31,698

)

(31,698

)

Cash NOI

140,170

 

104,164

 

124,491

 

 

368,825

 

Adjustments:

 

 

 

 

 

Cash NOI not included in same-store

(5,431

)

(1,750

)

(1,754

)

 

(8,935

)

Same-store cash NOI (constant currency)

$

134,739

 

$

102,414

 

$

122,737

 

$

 

$

359,890

 

Percentage (decrease) increase - constant currency

(54.7

%)

(12.7

%)

4.2

%

 

(32.4

%)

Adjusted Same-store cash NOI - constant currency

$

134,739

 

$

102,414

 

$

122,737

 

$

 

$

359,890

 

Adjusted percentage (decrease) increase - constant currency

(0.8

%)

(12.7

%)

4.2

%

 

(3.0

%)

For the Three Months Ended September 30, 2020

Net income attributable to common stockholders

 

 

 

 

$

12,751

 

Adjustments:

 

 

 

 

 

Interest and other income

 

 

 

 

(572

)

Interest expense

 

 

 

 

115,505

 

Depreciation and amortization

 

 

 

 

249,366

 

General, administrative and professional fees

 

 

 

 

32,081

 

Loss on extinguishment of debt, net

 

 

 

 

7,386

 

Merger-related expenses and deal costs

 

 

 

 

11,325

 

Allowance on loans receivable and investments

 

 

 

 

4,999

 

Other

 

 

 

 

5,681

 

Income from unconsolidated entities

 

 

 

 

(865

)

Gain on real estate dispositions

 

 

 

 

(12,622

)

Income tax benefit

 

 

 

 

(3,195

)

Net income attributable to noncontrolling interests

 

 

 

 

986

 

Reported segment NOI

$

150,738

 

$

118,669

 

$

133,325

 

$

20,094

 

$

422,826

 

Adjustments:

 

 

 

 

 

Straight-lining of rental income

(2,072

)

 

(2,576

)

 

(4,648

)

Non-cash rental income

(12,687

)

 

(5,936

)

 

(18,623

)

Cash impact of Brookdale lease modification

161,533

 

 

 

 

161,533

 

Write-off of straight-line rental income

14,312

 

 

5,970

 

 

20,282

 

NOI not included in cash NOI1

(10,934

)

(929

)

(10,890

)

 

(22,753

)

Non-segment NOI

 

 

 

(20,094

)

(20,094

)

NOI impact from change in FX

419

 

2,260

 

 

 

2,679

 

Cash NOI

$

301,309

 

$

120,000

 

$

119,893

 

$

 

$

541,202

 

Adjustments:

 

 

 

 

 

Cash NOI not included in same-store

(3,904

)

(2,740

)

(2,079

)

 

(8,723

)

NOI impact from change in FX not in same-store

 

2

 

 

 

2

 

Same-store cash NOI (constant currency)

$

297,405

 

$

117,262

 

$

117,814

 

$

 

$

532,481

 

Adjusted Same-store cash NOI:

 

 

 

 

 

Less cash impact of Brookdale lease modification

(161,533

)

 

 

 

(161,533

)

Adjusted Same-store cash NOI - constant currency

$

135,872

 

$

117,262

 

$

117,814

 

$

 

$

370,948

 

 

1 Excludes sold assets, Assets Held for Sale, development properties not yet operational and land parcels.

For the Three Months Ended September 30, 2021 and June 30, 2021

 

Triple-Net

Senior Housing

Operating

Office

Non-Segment

Total

For the Three Months Ended September 30, 2021

Net income attributable to common stockholders

 

 

 

 

$

60,680

 

Adjustments:

 

 

 

 

 

Interest and other income

 

 

 

 

(417

)

Interest expense

 

 

 

 

108,816

 

Depreciation and amortization

 

 

 

 

313,596

 

General, administrative and professional fees

 

 

 

 

30,259

 

Loss on extinguishment of debt, net

 

 

 

 

29,792

 

Merger-related expenses and deal costs

 

 

 

 

22,662

 

Allowance on loans receivable and investments

 

 

 

 

(60

)

Other

 

 

 

 

33,673

 

Income from unconsolidated entities

 

 

 

 

(2,772

)

Gain on real estate dispositions

 

 

 

 

(150,292

)

Income tax expense

 

 

 

 

3,780

 

Net income attributable to noncontrolling interests

 

 

 

 

2,094

 

Reported segment NOI

$

178,111

 

$

104,380

 

$

137,622

 

$

31,698

 

$

451,811

 

Adjustments:

 

 

 

 

 

Straight-lining of rental income

(1,854

)

 

(1,713

)

 

(3,567

)

Non-cash rental income

(11,713

)

 

(5,491

)

 

(17,204

)

Non-cash impact of lease termination

(22,309

)

 

 

 

(22,309

)

NOI not included in cash NOI1

(2,065

)

(216

)

(5,927

)

 

(8,208

)

Non-segment NOI

 

 

 

(31,698

)

(31,698

)

Cash NOI

140,170

 

104,164

 

124,491

 

 

368,825

 

Adjustments:

 

 

 

 

 

Cash NOI not included in same-store

(4,381

)

2,508

 

(1,754

)

 

(3,627

)

Same-store cash NOI (constant currency)

$

135,789

 

$

106,672

 

$

122,737

 

$

 

$

365,198

 

Percentage increase (decrease) - constant currency

0.5

%

(3.4

%)

(7.7

%)

 

(3.5

%)

 

 

 

 

 

 

For the Three Months Ended June 30, 2021

Net income attributable to common stockholders

 

 

 

 

$

86,391

 

Adjustments:

 

 

 

 

 

Interest and other income

 

 

 

 

(585

)

Interest expense

 

 

 

 

110,051

 

Depreciation and amortization

 

 

 

 

250,700

 

General, administrative and professional fees

 

 

 

 

30,588

 

Gain on extinguishment of debt, net

 

 

 

 

(74

)

Merger-related expenses and deal costs

 

 

 

 

721

 

Allowance on loans receivable and investments

 

 

 

 

(59

)

Other

 

 

 

 

(13,490

)

Income from unconsolidated entities

 

 

 

 

(4,767

)

Gain on real estate dispositions

 

 

 

 

(41,258

)

Income tax expense

 

 

 

 

3,641

 

Net income attributable to noncontrolling interests

 

 

 

 

1,897

 

Reported segment NOI

$

154,791

 

$

111,139

 

$

137,320

 

$

20,506

 

$

423,756

 

Adjustments:

 

 

 

 

 

Straight-lining of rental income

(1,808

)

 

(1,496

)

 

(3,304

)

Non-cash rental income

(11,905

)

 

(4,478

)

 

(16,383

)

Cash modification / termination fees

 

 

12,037

 

 

12,037

 

NOI not included in cash NOI1

(2,296

)

(1,312

)

(8,692

)

 

(12,300

)

Non-segment NOI

 

 

 

(20,506

)

(20,506

)

NOI impact from change in FX

(93

)

(1,103

)

 

 

(1,196

)

Cash NOI

$

138,689

 

$

108,724

 

$

134,691

 

$

 

$

382,104

 

Adjustments:

 

 

 

 

 

Cash NOI not included in same-store

(3,554

)

1,640

 

(1,692

)

 

(3,606

)

NOI impact from change in FX not in same-store

 

26

 

 

 

26

 

Same-store cash NOI (constant currency)

$

135,135

 

$

110,390

 

$

132,999

 

$

 

$

378,524

 

 

1 Excludes sold assets, Assets Held for Sale, development properties not yet operational and land parcels.

The Company considers NOI and Same-store cash NOI as important supplemental measures because they allow investors, analysts and the Company’s management to assess its unlevered property-level operating results and to compare its operating results with those of other real estate companies and between periods on a consistent basis. The Company defines NOI as total revenues, less interest and other income, property-level operating expenses and office building services costs. In the case of NOI, cash receipts may differ due to straight-line recognition of certain rental income and the application of other GAAP policies. The Company defines same-store as properties owned, consolidated and operational for the full period in both comparison periods and are not otherwise excluded; provided, however, that the Company may include selected properties that otherwise meet the same-store criteria if they are included in substantially all of, but not a full, period for one or both of the comparison periods, and in the Company’s judgment such inclusion provides a more meaningful presentation of its portfolio performance. Newly acquired development properties and recently developed or redeveloped properties in the Company’s Seniors Housing Operating Portfolio (“SHOP”) will be included in same-store once they are stabilized for the full period in both periods presented. These properties are considered stabilized upon the earlier of (a) the achievement of 80% sustained occupancy or (b) 24 months from the date of acquisition or substantial completion of work. Recently developed or redeveloped properties in the Office and Triple-Net Leased Portfolios will be included in same-store once substantial completion of work has occurred for the full period in both periods presented. SHOP and Triple-Net Leased properties that have undergone operator or business model transitions will be included in same-store once operating under consistent operating structures for the full period in both periods presented.

Properties are excluded from same-store if they are: (i) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (ii) impacted by materially disruptive events such as flood or fire; (iii) for SHOP, those properties that are currently undergoing a materially disruptive redevelopment; (iv) for the Office and Triple-Net Leased Portfolios, those properties for which management has an intention to institute, or has instituted, a redevelopment plan because the properties may require major property-level expenditures to maximize value, increase net operating income, or maintain a market-competitive position and/or achieve property stabilization, most commonly as the result of an expected or actual material change in occupancy or NOI; or (v) for the SHOP and Triple-Net Leased Portfolios, those properties that are scheduled to undergo operator or business model transitions, or have transitioned operators or business models after the start of the prior comparison period.

To eliminate the impact of exchange rate movements, all portfolio performance-based disclosures assume constant exchange rates across comparable periods, using the following methodology: the current period’s results are shown in actual reported USD, while prior comparison period’s results are adjusted and converted to USD based on the average exchange rate for the current period.

Contacts

Sarah Whitford

(877) 4-VENTAS

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.